The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs (Q48944762)

17 February 2018

title

The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs (English)

1 reference

17 February 2018

author name string

Parichehr Hassanzadeh

series ordinal

1

1 reference

17 February 2018

Sina Rahimpour

series ordinal

2

1 reference

17 February 2018

publication date

18 December 2010

1 reference

17 February 2018

number of pages

13

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

17 February 2018

volume

215

1 reference

17 February 2018

issue

1

1 reference

17 February 2018

page(s)

129-141

1 reference

17 February 2018

Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

NGF regulatory role in stress and coping of rodents and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Endocannabinoids in the treatment of mood disorders: evidence from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Selective antibody-induced cholinergic cell and synapse loss produce sustained hippocampal and cortical hypometabolism with correlated cognitive deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

A neutral CB1 receptor antagonist reduces weight gain in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

NGF is essential for hippocampal plasticity and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Function and evolution in the NGF family and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Time-dependent increase in basic fibroblast growth factor protein in limbic regions following electroshock seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Serotonergic lesion of median raphe nucleus alters nerve growth factor content and vulnerability of cholinergic septohippocampal neurons in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimers Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Physiology and neurobiology of stress and adaptation: central role of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Current trends in the development of new antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

A possible role for the endocannabinoid system in the neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Endocannabinoid system and stress and anxiety responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Risperidone attenuates brain damage after focal cerebral ischemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Endocannabinoid system and synaptic plasticity: implications for emotional responses

21 January 2018

1 reference

12 December 2020

Use of atypical antipsychotics in refractory depression and anxiety.

1 reference

12 December 2020

Neuromodulatory functions of the endocannabinoid system

1 reference

12 December 2020

Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues

1 reference

12 December 2020

Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors.

1 reference

12 December 2020

Nerve growth factor (NGF) content in adult rat brain tissues is several-fold higher than generally reported and is largely associated with sedimentable fractions

1 reference

12 December 2020

10.1007/S00213-010-2120-4

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018